Cargando…

Serum HE4: An Independent Prognostic Factor in Non-Small Cell Lung Cancer

Human epididymis secretory protein 4 (HE4) is a secreted glycosylated protein encoded by the WAP four-disulfide core domain 2 (WFDC2) gene, located on a chromosome 20 segment that is frequently amplified in many cancers. This study aimed at determining serum HE4 prognostic value in non-small cell lu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lamy, Pierre-Jean, Plassot, Carine, Pujol, Jean-Louis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452338/ https://www.ncbi.nlm.nih.gov/pubmed/26030627 http://dx.doi.org/10.1371/journal.pone.0128836

Ejemplares similares

Serum EGF-receptor and HER-2 extracellular domains and prognosis of non-small-cell lung cancer
por: Jacot, W, et al.
Publicado: (2004)

Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer
por: El Demery, Mounira, et al.
Publicado: (2014)

Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients
por: Bignotti, Eliana, et al.
Publicado: (2020)

Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients
por: Darlix, Amélie, et al.
Publicado: (2016)

The Application Value of Serum HE4 in the Diagnosis of Lung Cancer
por: Wang, Yuhui, et al.
Publicado: (2019)

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients
por: Bignotti, E, et al.
Publicado: (2011)

Detection of serum HE4 levels contributes to the diagnosis of lung cancer
por: Li, Jun, et al.
Publicado: (2023)

The ABO Blood Group is an Independent Prognostic Factor in Patients With Resected Non-small Cell Lung Cancer
Publicado: (2015)

Usefulness of serum HE4 in endometriotic cysts
por: Montagnana, M, et al.
Publicado: (2009)

A positive fluid balance is an independent prognostic factor in patients with sepsis
por: Acheampong, Angela, et al.
Publicado: (2015)

High EGFR protein expression and exon 9 PIK3CA mutations are independent prognostic factors in triple negative breast cancers
por: Jacot, William, et al.
Publicado: (2015)

Baseline anemia and anemia grade are independent prognostic factors for stage IV non-small cell lung cancer
por: Chen, Cheng, et al.
Publicado: (2021)

HnRNPAB is an independent prognostic factor in non‑small cell lung cancer and is involved in cell proliferation and metastasis
por: Wang, Qinrong, et al.
Publicado: (2023)

Prognostic value of CD4+ T lymphopenia in non-small cell lung Cancer
por: Eberst, Guillaume, et al.
Publicado: (2022)

Serum cholinesterase may independently predict prognosis in non-small-cell lung cancer
por: Ran, Hailiang, et al.
Publicado: (2022)

Diagnostic and Prognostic Values of Serum EpCAM, TGM2, and HE4 Levels in Endometrial Cancer
por: Lan, Ting, et al.
Publicado: (2020)

Positive tumour CD47 expression is an independent prognostic factor for recurrence in resected non-small cell lung cancer
por: Xu, Yan, et al.
Publicado: (2020)

Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab
por: Herbreteau, Guillaume, et al.
Publicado: (2020)

Duration of nivolumab for pretreated, advanced non–small‐cell lung cancer
por: Geier, Margaux, et al.
Publicado: (2020)

Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trials
por: Laporte, Silvy, et al.
Publicado: (2013)

Thermodynamic properties of HE3-HE4 solutions with applications to the HE3-HE4 dilution refrigerator
por: Radebaugh, R
Publicado: (1967)

The prognostic significance of fibroblast growth factor receptor 4 in non-small-cell lung cancer
por: Huang, Hong-ping, et al.
Publicado: (2015)

Editorial: Prognostic factors in non-small cell lung cancer
por: Rahouma, Mohamed, et al.
Publicado: (2023)

Diagnostic and prognostic value of serum periostin in patients with non-small cell lung cancer
por: Xu, Chun-Hua, et al.
Publicado: (2016)

Prognostic significance of serum chemerin levels in patients with non-small cell lung cancer
por: Xu, Chun-Hua, et al.
Publicado: (2017)

Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy
por: Berardi, Rossana, et al.
Publicado: (2016)

Inhibin βA is an independent prognostic factor that promotes invasion via Hippo signaling in non-small cell lung cancer
por: Zhang, Yijun, et al.
Publicado: (2021)

Eligibility for Bevacizumab as an Independent Prognostic Factor for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study
por: Takagi, Yusuke, et al.
Publicado: (2013)

Non-relativistic approximations to the pion production operator in $^{4}He(p, n \pi^{+})^{4}He$
por: Greben, J M, et al.
Publicado: (1979)

An individual patient-data meta-analysis of metronomic oral vinorelbine in metastatic non-small cell lung cancer
por: Pujol, Jean-Louis, et al.
Publicado: (2019)

Naples Prognostic Score is an Independent Prognostic Factor in Patients with Small Cell Lung Cancer and Nomogram Predictive Model Established
por: Chen, Shuangqing, et al.
Publicado: (2022)

Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors
por: Jacot, W, et al.
Publicado: (2001)

Serum dickkopf-1 as a clinical and prognostic factor in non-small cell lung cancer patients with bone metastases
por: Qiao, Rong, et al.
Publicado: (2017)

Limitations in the Use of Serum Epidermal Growth Factor Receptor Mutations as Prognostic Markers for Non-Small-Cell Lung Cancer
por: Zhang, Yongjun, et al.
Publicado: (2015)

Clinical evaluation of serum tumour marker CA 242 in non-small cell lung cancer.
por: Pujol, J. L., et al.
Publicado: (1993)

Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer
por: Choi, Chang-Min, et al.
Publicado: (2011)

A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index
por: Colinet, B, et al.
Publicado: (2005)

Tumor Mutation Load: A Novel Independent Prognostic Factor in Stage IIIA-N2 Non-Small-Cell Lung Cancer
por: Kang, Jingjing, et al.
Publicado: (2019)

Tumor size, but not consolidation‐to‐tumor ratio, is an independent prognostic factor for part‐solid clinical T1 non‐small cell lung cancer
por: Li, Zhihua, et al.
Publicado: (2022)

Serum level of DKK-1 and its prognostic potential in non–small cell lung cancer
por: Dong, Liang-liang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jhoitqdamf459m297o40ntvt8u